Vice President of Finance

About Quetzal Therapeutics LLC

Quetzal Therapeutics (Quetzal) is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL). The company plans to initiate Phase III clinical trials by late‑2025, with enabling activities ongoing. Quetzal is also developing a pre‑clinical asset QTX-2102, an advanced, next‑generation antifungal and antiparasitic therapy designed to enhance efficacy while minimizing toxicity.

The VP of Finance will be a key strategic partner to the executive team, responsible for overseeing all financial operations and driving the company’s financial strategy to support the company’s mission. This role requires a highly analytical and detail‑oriented individual with a deep understanding of biotech specific regulatory landscape, FP&A, and financial strategy as the company goes through Phase III trials.

The ideal candidate will provide insightful analysis, manage complex financial models related to R&D and clinical programs, and ensure robust financial reporting and compliance.

• Financial Planning & Analysis (FP&A):
  Lead the annual budgeting, quarterly forecasting, and long‑term financial planning processes. Develop and maintain complex financial models to support strategic decision‑making, including cash flow projections, capital expenditures, and R&D program evaluations.
• Clinical Finance:
  Act as the primary finance partner for clinical operations leadership, managing budgets for various projects and clinical trials, tracking costs by program, and providing analysis to support pipeline decision‑making.
• Strategy:
  Collaborate with the CMO, CSO, and Chief Legal Officer on clinical contracts and budgeting for upcoming Phase 3 trials. Lead financial material presentation for Board of Directors.
• Financial Reporting & Compliance:
  Oversee the timely review of monthly, quarterly, and annual financial statements in accordance with GAAP. Ensure compliance with all financial laws, guidelines, and reporting requirements. Coordinate annual tax work and R&D credit analysis (E&Y is company’s existing tax partner).
• Accounting Operations:
  Supervise day‑to‑day accounting functions (leveraging the Family Office and outsourced bookkeeping team), including general ledger, accounts payable/receivable, payroll, and tax filings.

• Education:
  
  Bachelor's degree in accounting, Finance, Business Administration, or a related field is required. An MBA, CPA, or CMA is strongly preferred.
• Experience:
  
  A minimum of 10 years of progressive experience in finance or accounting, with at least 5 years in a management or leadership role.
• Biotech/Pharma
  
  Experience:
  
  Prior experience in the biotechnology, pharmaceutical, or life sciences industry is highly preferred, including specific knowledge of drug trials, R&D credits, and intellectual property‑related financial complexities.
• Technical
  
  Skills:
  
  Expert knowledge of GAAP and financial modeling techniques. Advanced proficiency in financial software.
• Soft Skills:
  
  Strong analytical, problem‑solving, and decision‑making abilities. Excellent written and verbal communication skills, with a proven ability to present complex financial information to executive leadership, board members, and investors.
• Attributes:
  Ability to thrive in a dynamic, fast‑paced work environment, manage multiple priorities, and react to change productively.